88IV - PR Newswire Asia's news


Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) Limited Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate consideration of USD250,000,000 (approximately RMB1,721,650,000), ... 2026-04-08T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market NORWALK, Conn. , April 8, 2026 /PRNewswire/ -- LBB Specialties (LBBS), a North American distributor of specialty chemicals and ingredients providing technical solutions with a customer-first approach, ... 2026-04-08T Biotechnology Chemical Food/Beverages Health Care/Hospital
Live Cell Observation System Selected for NASA-Supported Project Heading to the International Space Station Nikon Contributes to Research on the Effects of Microgravity in Drug Discovery ... 2026-04-07T Biotechnology Computer/Electronics Health Care/Hospital
Singlomics Announces First Patient Dosed in Phase I Clinical Trial of DXP-106 (IL-1RAP mAb) in China BEIJING , April 7, 2026 /PRNewswire/ -- Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for oncology, ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development -Fixed - dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Akeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L)1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026 HONG KONG , April 7, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that, at the 2026 European Lung Cancer Congress (ELCC 2026), it reported updated ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results - Presented key product lines spanning aesthetic, wound care, bone and spine, and surgical fields - Signed supply agreements totaling KRW 5.3 billion with partners from Singapore, Malaysia, Pakistan, ... 2026-04-07T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement MELBOURNE, Australia and INDIANAPOLIS , April 7, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a market update on its commercial and operational ... 2026-04-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-04-06T Banking/Financial Service Biotechnology Computer/Electronics
Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, improving patient throughput, and supporting a more cost-effective ... 2026-04-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology